Oligonucleotide primers employed at melting temperatures (TM in °C) used to determine the expression of RLN2, human RXFP1 relaxin receptor (RXFP1), S100A4 and 18S transcripts in human breast cancer cell lines and xenograft tumours. This evidence concerns the gene RLN2 and breast carcinoma.